| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking | 104 | 2020 | 860 | 14.300 |
Why?
|
| Tobacco Use Disorder | 74 | 2020 | 246 | 13.370 |
Why?
|
| Adolescent Behavior | 51 | 2020 | 194 | 6.110 |
Why?
|
| Smoking Prevention | 37 | 2018 | 163 | 4.800 |
Why?
|
| Substance Withdrawal Syndrome | 18 | 2016 | 124 | 4.110 |
Why?
|
| Behavior, Addictive | 20 | 2020 | 75 | 3.730 |
Why?
|
| Commerce | 19 | 2020 | 59 | 3.590 |
Why?
|
| Personal Autonomy | 17 | 2015 | 71 | 3.540 |
Why?
|
| Nicotine | 19 | 2017 | 118 | 2.990 |
Why?
|
| Adolescent | 116 | 2020 | 6293 | 2.970 |
Why?
|
| Tobacco Products | 9 | 2020 | 63 | 2.750 |
Why?
|
| Smoking Cessation | 31 | 2020 | 552 | 2.510 |
Why?
|
| Tobacco Industry | 13 | 2014 | 19 | 2.350 |
Why?
|
| Tobacco Smoke Pollution | 6 | 2016 | 56 | 1.740 |
Why?
|
| Minors | 6 | 2020 | 9 | 1.690 |
Why?
|
| Male | 96 | 2020 | 30811 | 1.250 |
Why?
|
| Female | 95 | 2020 | 33770 | 1.190 |
Why?
|
| Humans | 140 | 2020 | 64795 | 1.170 |
Why?
|
| Psychometrics | 17 | 2016 | 392 | 1.120 |
Why?
|
| Child | 42 | 2016 | 4603 | 1.110 |
Why?
|
| Craving | 5 | 2016 | 38 | 0.930 |
Why?
|
| Students | 7 | 2016 | 226 | 0.920 |
Why?
|
| Surveys and Questionnaires | 20 | 2018 | 2754 | 0.910 |
Why?
|
| Nicotinic Agonists | 5 | 2015 | 39 | 0.860 |
Why?
|
| Brain | 9 | 2020 | 1598 | 0.840 |
Why?
|
| Smokers | 4 | 2020 | 117 | 0.790 |
Why?
|
| State Government | 3 | 2018 | 32 | 0.790 |
Why?
|
| Law Enforcement | 4 | 2011 | 27 | 0.760 |
Why?
|
| Health Education | 6 | 2008 | 191 | 0.740 |
Why?
|
| Drug and Narcotic Control | 5 | 2011 | 27 | 0.740 |
Why?
|
| Receptors, Nicotinic | 3 | 2020 | 69 | 0.730 |
Why?
|
| Water Pipe Smoking | 5 | 2020 | 9 | 0.720 |
Why?
|
| Family | 3 | 2016 | 245 | 0.700 |
Why?
|
| United States | 31 | 2020 | 8036 | 0.690 |
Why?
|
| Attitude to Health | 5 | 2011 | 296 | 0.640 |
Why?
|
| Plants, Toxic | 6 | 1999 | 13 | 0.630 |
Why?
|
| Child Behavior | 10 | 2010 | 65 | 0.600 |
Why?
|
| Young Adult | 15 | 2020 | 4777 | 0.600 |
Why?
|
| Counseling | 6 | 2015 | 374 | 0.600 |
Why?
|
| Parents | 6 | 2015 | 401 | 0.590 |
Why?
|
| Population Surveillance | 2 | 2018 | 209 | 0.570 |
Why?
|
| Government Programs | 1 | 2018 | 19 | 0.570 |
Why?
|
| Substance-Related Disorders | 5 | 2020 | 749 | 0.570 |
Why?
|
| Motivation | 7 | 2016 | 295 | 0.570 |
Why?
|
| Massachusetts | 19 | 2015 | 2137 | 0.550 |
Why?
|
| Adult | 34 | 2016 | 17247 | 0.530 |
Why?
|
| Health Surveys | 8 | 2011 | 317 | 0.510 |
Why?
|
| Health Promotion | 6 | 2018 | 512 | 0.510 |
Why?
|
| Psychology, Adolescent | 6 | 2009 | 27 | 0.510 |
Why?
|
| Prevalence | 8 | 2016 | 1432 | 0.480 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2015 | 6 | 0.470 |
Why?
|
| Government Regulation | 3 | 2011 | 39 | 0.470 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 22 | 0.470 |
Why?
|
| Receptors, Opioid, mu | 1 | 2015 | 13 | 0.470 |
Why?
|
| Tobacco, Smokeless | 3 | 2011 | 8 | 0.460 |
Why?
|
| Marketing of Health Services | 3 | 2001 | 22 | 0.450 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2010 | 118 | 0.450 |
Why?
|
| Reproducibility of Results | 12 | 2015 | 1690 | 0.440 |
Why?
|
| Advisory Committees | 1 | 2015 | 111 | 0.440 |
Why?
|
| International Classification of Diseases | 3 | 2010 | 136 | 0.440 |
Why?
|
| Parietal Lobe | 1 | 2014 | 28 | 0.420 |
Why?
|
| Behavior Therapy | 1 | 2015 | 165 | 0.420 |
Why?
|
| Gyrus Cinguli | 1 | 2014 | 58 | 0.410 |
Why?
|
| Asthma | 3 | 2016 | 472 | 0.410 |
Why?
|
| Longitudinal Studies | 10 | 2020 | 1274 | 0.400 |
Why?
|
| Time Factors | 13 | 2018 | 3744 | 0.400 |
Why?
|
| Cross-Sectional Studies | 9 | 2016 | 2679 | 0.380 |
Why?
|
| Schools | 9 | 2020 | 169 | 0.370 |
Why?
|
| Inhalation Exposure | 1 | 2012 | 54 | 0.360 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2012 | 39 | 0.360 |
Why?
|
| Pediatrics | 3 | 2015 | 265 | 0.360 |
Why?
|
| Habits | 1 | 2011 | 21 | 0.350 |
Why?
|
| Age Factors | 9 | 2014 | 1580 | 0.340 |
Why?
|
| Risk Factors | 14 | 2015 | 5396 | 0.340 |
Why?
|
| Benzazepines | 1 | 2011 | 21 | 0.340 |
Why?
|
| Disease Progression | 2 | 2016 | 1211 | 0.340 |
Why?
|
| Child Welfare | 3 | 2008 | 51 | 0.340 |
Why?
|
| Maze Learning | 1 | 2011 | 51 | 0.340 |
Why?
|
| Drug Tolerance | 2 | 2011 | 33 | 0.340 |
Why?
|
| Impulsive Behavior | 1 | 2011 | 28 | 0.340 |
Why?
|
| Quinoxalines | 1 | 2011 | 37 | 0.330 |
Why?
|
| Mental Recall | 3 | 2014 | 95 | 0.330 |
Why?
|
| Guideline Adherence | 3 | 2009 | 302 | 0.320 |
Why?
|
| Primary Health Care | 1 | 2015 | 717 | 0.300 |
Why?
|
| New Zealand | 4 | 2016 | 44 | 0.300 |
Why?
|
| Psychological Theory | 2 | 2015 | 26 | 0.300 |
Why?
|
| Prospective Studies | 13 | 2016 | 3303 | 0.300 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2009 | 35 | 0.300 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 382 | 0.290 |
Why?
|
| Motor Activity | 1 | 2011 | 347 | 0.280 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2017 | 624 | 0.280 |
Why?
|
| Motion Pictures | 1 | 2007 | 11 | 0.270 |
Why?
|
| Social Control, Formal | 3 | 2001 | 20 | 0.260 |
Why?
|
| Health Behavior | 1 | 2010 | 482 | 0.260 |
Why?
|
| Ganglionic Stimulants | 1 | 2007 | 6 | 0.260 |
Why?
|
| Universities | 1 | 2008 | 167 | 0.250 |
Why?
|
| Personality Inventory | 1 | 2006 | 56 | 0.250 |
Why?
|
| Marketing | 3 | 2014 | 21 | 0.240 |
Why?
|
| Physician's Role | 4 | 2003 | 122 | 0.240 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 130 | 0.230 |
Why?
|
| Interpersonal Relations | 1 | 2006 | 157 | 0.230 |
Why?
|
| Tobacco Use Cessation | 2 | 2008 | 32 | 0.230 |
Why?
|
| Middle Aged | 12 | 2016 | 18122 | 0.230 |
Why?
|
| Odds Ratio | 7 | 2011 | 759 | 0.230 |
Why?
|
| Receptors, Cholinergic | 1 | 2005 | 23 | 0.220 |
Why?
|
| Menthol | 2 | 2017 | 6 | 0.220 |
Why?
|
| Manifest Anxiety Scale | 1 | 2004 | 2 | 0.220 |
Why?
|
| Rats | 5 | 2017 | 1997 | 0.210 |
Why?
|
| Taxes | 3 | 2000 | 6 | 0.210 |
Why?
|
| Models, Neurological | 1 | 2005 | 82 | 0.210 |
Why?
|
| Self-Assessment | 1 | 2004 | 59 | 0.210 |
Why?
|
| Social Class | 2 | 2014 | 138 | 0.210 |
Why?
|
| Peer Group | 3 | 2011 | 109 | 0.210 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 46 | 0.210 |
Why?
|
| Nurse's Role | 2 | 2011 | 123 | 0.210 |
Why?
|
| Cyprus | 2 | 2016 | 2 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2016 | 2240 | 0.210 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 1556 | 0.200 |
Why?
|
| Income | 2 | 2003 | 170 | 0.200 |
Why?
|
| Locomotion | 3 | 2017 | 114 | 0.200 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 86 | 0.200 |
Why?
|
| Cues | 3 | 2015 | 80 | 0.200 |
Why?
|
| Adolescent Medicine | 1 | 2003 | 6 | 0.200 |
Why?
|
| Social Environment | 3 | 2015 | 94 | 0.200 |
Why?
|
| Injections, Subcutaneous | 2 | 2015 | 69 | 0.200 |
Why?
|
| Pleasure | 2 | 2014 | 12 | 0.200 |
Why?
|
| Risk Assessment | 6 | 2014 | 2089 | 0.200 |
Why?
|
| Seasons | 1 | 2003 | 139 | 0.190 |
Why?
|
| Arousal | 2 | 2014 | 42 | 0.190 |
Why?
|
| Proportional Hazards Models | 3 | 2010 | 734 | 0.190 |
Why?
|
| Drug Administration Schedule | 2 | 2015 | 295 | 0.190 |
Why?
|
| Socioeconomic Factors | 3 | 2016 | 796 | 0.190 |
Why?
|
| Lebanon | 5 | 2020 | 10 | 0.180 |
Why?
|
| Factor Analysis, Statistical | 3 | 2015 | 100 | 0.180 |
Why?
|
| Causality | 2 | 2016 | 59 | 0.180 |
Why?
|
| Brain Mapping | 3 | 2016 | 240 | 0.170 |
Why?
|
| Anxiety | 1 | 2004 | 423 | 0.170 |
Why?
|
| Cohort Studies | 5 | 2009 | 2608 | 0.170 |
Why?
|
| Facility Regulation and Control | 1 | 2000 | 3 | 0.170 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2000 | 7 | 0.170 |
Why?
|
| Industry | 3 | 1996 | 59 | 0.170 |
Why?
|
| Logistic Models | 5 | 2016 | 1270 | 0.160 |
Why?
|
| Child, Preschool | 3 | 2016 | 2052 | 0.160 |
Why?
|
| Age Distribution | 3 | 2015 | 258 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 2270 | 0.160 |
Why?
|
| Sudden Infant Death | 2 | 2004 | 28 | 0.160 |
Why?
|
| Marijuana Smoking | 1 | 2020 | 19 | 0.160 |
Why?
|
| Marijuana Use | 1 | 2020 | 22 | 0.160 |
Why?
|
| Incidence | 3 | 2009 | 1409 | 0.160 |
Why?
|
| Private Sector | 1 | 1999 | 12 | 0.160 |
Why?
|
| Cluster Analysis | 2 | 2016 | 260 | 0.160 |
Why?
|
| Interviews as Topic | 3 | 2007 | 529 | 0.150 |
Why?
|
| Australia | 2 | 2010 | 128 | 0.150 |
Why?
|
| Aged | 7 | 2016 | 14847 | 0.150 |
Why?
|
| Vaping | 1 | 2020 | 50 | 0.150 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2017 | 160 | 0.150 |
Why?
|
| Research Design | 2 | 2015 | 583 | 0.150 |
Why?
|
| Retrospective Studies | 5 | 2018 | 6800 | 0.150 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2020 | 78 | 0.150 |
Why?
|
| Colorado | 1 | 2018 | 21 | 0.140 |
Why?
|
| Health Care Costs | 1 | 2001 | 224 | 0.140 |
Why?
|
| Infant | 4 | 2012 | 1685 | 0.140 |
Why?
|
| Age of Onset | 2 | 2008 | 173 | 0.140 |
Why?
|
| Sex Distribution | 2 | 2008 | 250 | 0.140 |
Why?
|
| Quebec | 2 | 2009 | 14 | 0.130 |
Why?
|
| Perception | 2 | 2009 | 181 | 0.130 |
Why?
|
| Brain Chemistry | 1 | 2017 | 76 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 430 | 0.130 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 2484 | 0.130 |
Why?
|
| Neural Pathways | 2 | 2016 | 103 | 0.130 |
Why?
|
| Public Policy | 2 | 1999 | 38 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 1160 | 0.130 |
Why?
|
| Visual Cortex | 1 | 2016 | 27 | 0.120 |
Why?
|
| Public Health | 2 | 2003 | 186 | 0.120 |
Why?
|
| Tobacco, Waterpipe | 1 | 2016 | 8 | 0.120 |
Why?
|
| Mississippi | 2 | 2015 | 15 | 0.120 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 929 | 0.120 |
Why?
|
| Relaxation | 2 | 2007 | 6 | 0.120 |
Why?
|
| Legislation as Topic | 3 | 1996 | 12 | 0.120 |
Why?
|
| Corpus Striatum | 1 | 2016 | 98 | 0.120 |
Why?
|
| Animals | 8 | 2017 | 21295 | 0.120 |
Why?
|
| Minisatellite Repeats | 1 | 2015 | 6 | 0.120 |
Why?
|
| Regression Analysis | 2 | 2010 | 497 | 0.120 |
Why?
|
| Alleles | 2 | 2015 | 454 | 0.120 |
Why?
|
| Stress, Psychological | 3 | 2011 | 472 | 0.120 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2015 | 37 | 0.120 |
Why?
|
| Binge Drinking | 1 | 2016 | 38 | 0.110 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 414 | 0.110 |
Why?
|
| Gene-Environment Interaction | 1 | 2015 | 52 | 0.110 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 155 | 0.110 |
Why?
|
| Genotype | 2 | 2015 | 675 | 0.110 |
Why?
|
| Restaurants | 2 | 2018 | 12 | 0.110 |
Why?
|
| Sex Factors | 3 | 2007 | 987 | 0.110 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 198 | 0.110 |
Why?
|
| Alcohol Drinking | 2 | 2016 | 322 | 0.110 |
Why?
|
| Legislation, Drug | 1 | 2014 | 22 | 0.110 |
Why?
|
| Patient Education as Topic | 2 | 2007 | 480 | 0.100 |
Why?
|
| Corpus Callosum | 1 | 2013 | 41 | 0.100 |
Why?
|
| Frontal Lobe | 1 | 2013 | 63 | 0.100 |
Why?
|
| Communication | 2 | 2015 | 593 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 850 | 0.100 |
Why?
|
| Netherlands | 1 | 2012 | 25 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 511 | 0.100 |
Why?
|
| Ethics, Pharmacy | 1 | 1992 | 3 | 0.090 |
Why?
|
| Academies and Institutes | 1 | 1992 | 24 | 0.090 |
Why?
|
| Depression | 3 | 2016 | 890 | 0.090 |
Why?
|
| Cartoons as Topic | 1 | 1991 | 1 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 694 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2008 | 1105 | 0.090 |
Why?
|
| Pharmacies | 1 | 1992 | 36 | 0.090 |
Why?
|
| Indians, North American | 1 | 2011 | 29 | 0.090 |
Why?
|
| Reference Values | 2 | 2011 | 328 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2012 | 1412 | 0.090 |
Why?
|
| Florida | 1 | 2011 | 45 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 798 | 0.090 |
Why?
|
| Data Collection | 2 | 2005 | 381 | 0.090 |
Why?
|
| Prisons | 1 | 2012 | 120 | 0.090 |
Why?
|
| School Nursing | 1 | 2011 | 30 | 0.090 |
Why?
|
| Varenicline | 1 | 2011 | 11 | 0.090 |
Why?
|
| United States Food and Drug Administration | 1 | 2011 | 90 | 0.080 |
Why?
|
| Greece | 1 | 2010 | 3 | 0.080 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 159 | 0.080 |
Why?
|
| Bias | 2 | 2002 | 116 | 0.080 |
Why?
|
| Lung Diseases | 1 | 2012 | 182 | 0.080 |
Why?
|
| Exploratory Behavior | 2 | 2008 | 36 | 0.080 |
Why?
|
| Otitis Media | 2 | 2004 | 12 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2011 | 178 | 0.080 |
Why?
|
| United Kingdom | 1 | 2010 | 86 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2011 | 232 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 1995 | 383 | 0.080 |
Why?
|
| Research | 1 | 2011 | 194 | 0.080 |
Why?
|
| Manuals as Topic | 1 | 2009 | 8 | 0.080 |
Why?
|
| Trust | 1 | 2011 | 79 | 0.080 |
Why?
|
| Physicians, Family | 2 | 2003 | 76 | 0.080 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2009 | 8 | 0.080 |
Why?
|
| New South Wales | 1 | 2009 | 3 | 0.080 |
Why?
|
| Linear Models | 2 | 2011 | 406 | 0.070 |
Why?
|
| Imagination | 1 | 2008 | 7 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2011 | 5757 | 0.070 |
Why?
|
| Personality Assessment | 1 | 2008 | 31 | 0.070 |
Why?
|
| Truth Disclosure | 1 | 2008 | 58 | 0.070 |
Why?
|
| Practice Management, Medical | 1 | 2008 | 20 | 0.070 |
Why?
|
| Internet | 1 | 2011 | 464 | 0.070 |
Why?
|
| Probability | 1 | 2008 | 168 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 214 | 0.070 |
Why?
|
| Parent-Child Relations | 1 | 2008 | 67 | 0.070 |
Why?
|
| Cotinine | 1 | 2007 | 19 | 0.070 |
Why?
|
| Rats, Inbred WKY | 2 | 2017 | 11 | 0.070 |
Why?
|
| Psychological Tests | 1 | 2007 | 47 | 0.070 |
Why?
|
| Life Style | 1 | 2009 | 320 | 0.060 |
Why?
|
| Nonprescription Drugs | 1 | 2007 | 17 | 0.060 |
Why?
|
| Endorphins | 1 | 2007 | 12 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 168 | 0.060 |
Why?
|
| Mass Media | 2 | 2006 | 32 | 0.060 |
Why?
|
| Saliva | 1 | 2007 | 99 | 0.060 |
Why?
|
| Intention | 1 | 2007 | 72 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2007 | 146 | 0.060 |
Why?
|
| Primary Prevention | 1 | 2008 | 136 | 0.060 |
Why?
|
| Needs Assessment | 1 | 2008 | 201 | 0.060 |
Why?
|
| Alcoholism | 1 | 1990 | 328 | 0.060 |
Why?
|
| Narcotics | 1 | 2007 | 57 | 0.060 |
Why?
|
| Serotonin | 1 | 2007 | 60 | 0.060 |
Why?
|
| Risk | 1 | 2007 | 377 | 0.060 |
Why?
|
| Norepinephrine | 1 | 2007 | 106 | 0.060 |
Why?
|
| Glutamic Acid | 1 | 2007 | 103 | 0.060 |
Why?
|
| Dopamine | 1 | 2007 | 106 | 0.060 |
Why?
|
| Consensus | 1 | 2007 | 181 | 0.060 |
Why?
|
| Attitude | 2 | 2003 | 101 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 2006 | 191 | 0.060 |
Why?
|
| Accidents, Traffic | 1 | 1986 | 145 | 0.060 |
Why?
|
| Financing, Organized | 1 | 2005 | 16 | 0.060 |
Why?
|
| Receptors, Muscarinic | 1 | 2005 | 18 | 0.060 |
Why?
|
| Internal-External Control | 1 | 2005 | 34 | 0.060 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2004 | 11 | 0.060 |
Why?
|
| Mixed Function Oxygenases | 1 | 2004 | 19 | 0.060 |
Why?
|
| Program Evaluation | 2 | 2011 | 489 | 0.050 |
Why?
|
| Hospitalization | 1 | 2012 | 1384 | 0.050 |
Why?
|
| Recurrence | 1 | 2006 | 659 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 768 | 0.050 |
Why?
|
| Homeostasis | 1 | 2007 | 378 | 0.050 |
Why?
|
| Dizziness | 1 | 2004 | 19 | 0.050 |
Why?
|
| Intelligence | 1 | 2004 | 51 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 1122 | 0.050 |
Why?
|
| Nursing Methodology Research | 1 | 2003 | 53 | 0.050 |
Why?
|
| Family Characteristics | 1 | 2003 | 45 | 0.050 |
Why?
|
| Texas | 1 | 2003 | 59 | 0.050 |
Why?
|
| Nausea | 1 | 2004 | 110 | 0.050 |
Why?
|
| Personality | 1 | 2003 | 29 | 0.050 |
Why?
|
| Pregnancy | 2 | 2004 | 2361 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2006 | 427 | 0.050 |
Why?
|
| Self Report | 2 | 2016 | 390 | 0.050 |
Why?
|
| Risk-Taking | 1 | 2003 | 160 | 0.050 |
Why?
|
| Interview, Psychological | 1 | 2002 | 79 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2002 | 78 | 0.050 |
Why?
|
| Politics | 1 | 2002 | 37 | 0.050 |
Why?
|
| Educational Status | 1 | 2003 | 277 | 0.040 |
Why?
|
| Models, Econometric | 1 | 2001 | 14 | 0.040 |
Why?
|
| Smoking Water Pipes | 1 | 2020 | 6 | 0.040 |
Why?
|
| Management Audit | 1 | 2000 | 3 | 0.040 |
Why?
|
| Cross-Cultural Comparison | 1 | 2000 | 48 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2001 | 233 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2008 | 605 | 0.040 |
Why?
|
| Crime | 1 | 2000 | 57 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 315 | 0.040 |
Why?
|
| Chewing Gum | 2 | 2007 | 9 | 0.030 |
Why?
|
| Rats, Inbred SHR | 1 | 2016 | 5 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 706 | 0.030 |
Why?
|
| Adenoidectomy | 1 | 1996 | 7 | 0.030 |
Why?
|
| Middle Ear Ventilation | 1 | 1996 | 3 | 0.030 |
Why?
|
| Tonsillectomy | 1 | 1996 | 12 | 0.030 |
Why?
|
| Fires | 1 | 1996 | 17 | 0.030 |
Why?
|
| Bronchitis | 1 | 1996 | 30 | 0.030 |
Why?
|
| Self Concept | 1 | 2016 | 118 | 0.030 |
Why?
|
| Germany | 1 | 2016 | 54 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 1 | 1996 | 39 | 0.030 |
Why?
|
| Office Visits | 1 | 1996 | 48 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2016 | 92 | 0.030 |
Why?
|
| Models, Psychological | 1 | 1995 | 101 | 0.030 |
Why?
|
| Fetal Death | 1 | 1995 | 15 | 0.030 |
Why?
|
| Infant Mortality | 1 | 1995 | 21 | 0.030 |
Why?
|
| Abortion, Spontaneous | 1 | 1995 | 30 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 1995 | 61 | 0.030 |
Why?
|
| Cough | 1 | 1996 | 184 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 1996 | 223 | 0.030 |
Why?
|
| Canada | 1 | 2014 | 152 | 0.030 |
Why?
|
| Health Policy | 1 | 1996 | 192 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 1115 | 0.030 |
Why?
|
| Anisotropy | 1 | 2013 | 63 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 1996 | 255 | 0.020 |
Why?
|
| Pneumonia | 1 | 1996 | 291 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 74 | 0.020 |
Why?
|
| Pattern Recognition, Visual | 1 | 1991 | 37 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 238 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 1992 | 229 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2011 | 365 | 0.020 |
Why?
|
| Decision Making | 1 | 1992 | 415 | 0.020 |
Why?
|
| Role Playing | 1 | 1988 | 8 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2008 | 49 | 0.020 |
Why?
|
| Tablets | 1 | 2007 | 16 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2007 | 31 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 1990 | 1142 | 0.020 |
Why?
|
| Ethanol | 1 | 1990 | 329 | 0.020 |
Why?
|
| Oxygen | 1 | 2008 | 317 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2008 | 236 | 0.010 |
Why?
|
| Cytochrome P-450 CYP2A6 | 1 | 2004 | 1 | 0.010 |
Why?
|
| Social Behavior | 1 | 2005 | 88 | 0.010 |
Why?
|
| Self Efficacy | 1 | 2005 | 201 | 0.010 |
Why?
|
| Health Planning Guidelines | 1 | 2003 | 31 | 0.010 |
Why?
|
| Organizational Policy | 1 | 2003 | 52 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2002 | 34 | 0.010 |
Why?
|
| Demography | 1 | 2002 | 179 | 0.010 |
Why?
|
| Family Practice | 1 | 2003 | 216 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2003 | 457 | 0.010 |
Why?
|
| Focus Groups | 1 | 2002 | 318 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 744 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 460 | 0.010 |
Why?
|
| Emotions | 1 | 2002 | 228 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 727 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 5575 | 0.010 |
Why?
|